» Articles » PMID: 15929862

Glucokinase, Glucose Homeostasis, and Diabetes Mellitus

Overview
Journal Curr Diab Rep
Publisher Current Science
Specialty Endocrinology
Date 2005 Jun 3
PMID 15929862
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The enzyme glucokinase (GK) regulates the rate of glucose metabolism in many tissues, including liver, the pancreatic b cells, certain neurons, enteroendocrine cells, and the pituitary, serving as a glucose sensor in many of these. Thus, GK plays a critical role in glucose homeostasis. Spontaneous mutants of GK in humans result in autosomal-dominant hypo- and hyperglycemia syndromes described as "GK disease." GK activator drugs have been discovered that lower blood glucose in normal and diabetic animals and promise to be useful in the treatment of type 2 diabetes mellitus. There is no question that the GK molecule and related issues will continue to be a fruitful topic for future research.

Citing Articles

Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes.

Yamagata K, Tsuyama T, Sato Y Int J Mol Sci. 2024; 25(8).

PMID: 38673770 PMC: 11050445. DOI: 10.3390/ijms25084186.


Genetic perspectives on childhood monogenic diabetes: Diagnosis, management, and future directions.

Sun H, Lin X World J Diabetes. 2024; 14(12):1738-1753.

PMID: 38222792 PMC: 10784795. DOI: 10.4239/wjd.v14.i12.1738.


Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China.

Song L, Cao F, Niu S, Xu M, Liang R, Ding K Clin Pharmacokinet. 2023; 63(1):93-108.

PMID: 37985591 DOI: 10.1007/s40262-023-01321-8.


Proteomics identifies the developmental regulation of HKDC1 in liver of pigs and mice.

Martinez-Garza U, Choi J, Scafidi S, Wolfgang M Am J Physiol Regul Integr Comp Physiol. 2023; 325(4):R389-R400.

PMID: 37545422 PMC: 10639021. DOI: 10.1152/ajpregu.00253.2022.


The genetic polymorphisms Associated with type 2 diabetes Mellitus.

Jin H, Jung D Indian J Clin Biochem. 2023; 38(3):385-392.

PMID: 37234182 PMC: 10205947. DOI: 10.1007/s12291-022-01057-5.


References
1.
Christesen H, Jacobsen B, Odili S, Buettger C, Cuesta-Munoz A, Hansen T . The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy. Diabetes. 2002; 51(4):1240-6. DOI: 10.2337/diabetes.51.4.1240. View

2.
Magnuson M . Glucokinase gene structure. Functional implications of molecular genetic studies. Diabetes. 1990; 39(5):523-7. DOI: 10.2337/diab.39.5.523. View

3.
Gloyn A . Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat. 2003; 22(5):353-62. DOI: 10.1002/humu.10277. View

4.
Gloyn A, Noordam K, Willemsen M, Ellard S, Lam W, Campbell I . Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes. 2003; 52(9):2433-40. DOI: 10.2337/diabetes.52.9.2433. View

5.
Collins H, Najafi H, Buettger C, Rombeau J, Settle R, Matschinsky F . Identification of glucose response proteins in two biological models of beta-cell adaptation to chronic high glucose exposure. J Biol Chem. 1992; 267(2):1357-66. View